Related Experiment Video
Updated: Dec 17, 2025

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
Published on: February 7, 2022
Heart transplant recipient patient with COVID-19 treated with tocilizumab
Massimo Mattioli1, Elisa Fustini1, Silvia Gennarini1
1UOC Pronto Soccorso e Medicina d'Urgenza, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy.
Abstract:
A heart transplant 62-year-old patient referred for coronavirus-19 disease (COVID-19) pneumonia. At admission, he was febrile, tachypnoeic, and mild hypoxic with dry cough; during hospitalization, a diffuse morbilliform skin rash appeared. He was treated with tocilizumab with symptoms improvement, without a complete pulmonary function recovery. Skin rash, highly suggestive for COVID-19 cutaneous involvement, persisted for ten days despite tocilizumab administration.
Related Concept Videos
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Pericarditis III: Medical Management
Myocarditis IV: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Rheumatic Heart Disease IV: Nursing Management

